Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform-powered by data from more than 100 million patient records and encompassing trillions of facts-as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.
Company profile
Ticker
HCAT
Exchange
Website
CEO
Daniel D. Burton
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Alphabet • Meta Platforms • Rackspace Technology • IHS Markit • Sabre • IAC • Baidu • Bumble • Match • Twitter ...
Former names
HQC Holdings, Inc.
SEC CIK
Corporate docs
Subsidiaries
Medicity LLC • Health Catalyst UK Ltd • Health Catalyst Singapore Pte. Ltd. • Able Health, LLC • Healthfinch, LLC • Vitalware, LLC • Twistle, LLC ...
IRS number
453337483
HCAT stock data
Analyst ratings and price targets
Current price
Average target
$14.33
Low target
$11.00
High target
$17.00
Evercore ISI Group
Downgraded
$11.00
Raymond James
Maintains
$15.00
SVB Leerink
Maintains
$17.00
Latest filings (excl ownership)
8-K
Overview Presentation January 2023
9 Jan 23
8-K
Health Catalyst Announces New, External Leadership Assignment for Paul Horstmeier
6 Jan 23
8-K/A
Departure of Directors or Certain Officers
6 Jan 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
Health Catalyst Reports Third Quarter 2022 Results
8 Nov 22
8-K
Health Catalyst Announces New Leadership Assignments in Support of Strategic Focus Areas
7 Sep 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
8-K
Health Catalyst Announces $40 Million Share Repurchase Program
4 Aug 22
8-K
Health Catalyst Reports Second Quarter 2022 Results
4 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 22
Transcripts
HCAT
Earnings call transcript
2022 Q2
7 Aug 22
HCAT
Earnings call transcript
2022 Q1
11 May 22
HCAT
Earnings call transcript
2021 Q4
2 Mar 22
HCAT
Earnings call transcript
2021 Q3
10 Nov 21
HCAT
Earnings call transcript
2021 Q2
8 Aug 21
HCAT
Earnings call transcript
2021 Q1
9 May 21
HCAT
Earnings call transcript
2020 Q4
1 Mar 21
HCAT
Earnings call transcript
2020 Q3
10 Nov 20
HCAT
Earnings call transcript
2020 Q2
11 Aug 20
HCAT
Earnings call transcript
2020 Q1
12 May 20
Latest ownership filings
Financial summary
| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 124.22 mm | 124.22 mm | 124.22 mm | 124.22 mm | 124.22 mm | 124.22 mm |
| Cash burn (monthly) | 17.59 mm | 12.63 mm | 15.24 mm | 12.34 mm | 4.01 mm | 2.52 mm |
| Cash used (since last report) | 72.50 mm | 52.06 mm | 62.83 mm | 50.85 mm | 16.53 mm | 10.38 mm |
| Cash remaining | 51.72 mm | 72.16 mm | 61.39 mm | 73.37 mm | 107.69 mm | 113.84 mm |
| Runway (months of cash) | 2.9 | 5.7 | 4.0 | 5.9 | 26.9 | 45.2 |
Institutional ownership, Q3 2022
86.0% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 168 |
| Opened positions | 31 |
| Closed positions | 40 |
| Increased positions | 71 |
| Reduced positions | 42 |
| 13F shares | Current |
|---|---|
| Total value | 457.13 mm |
| Total shares | 47.10 mm |
| Total puts | 79.20 k |
| Total calls | 196.20 k |
| Total put/call ratio | 0.4 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 5.94 mm | $57.63 mm |
| BLK Blackrock | 4.62 mm | $44.80 mm |
| Wellington Management | 2.51 mm | $24.38 mm |
| Millennium Management | 1.94 mm | $18.83 mm |
| Point72 Asset Management | 1.93 mm | $18.71 mm |
| GS Goldman Sachs | 1.88 mm | $18.19 mm |
| JPM JPMorgan Chase & Co. | 1.43 mm | $13.87 mm |
| First Light Asset Management | 1.15 mm | $11.15 mm |
| Balyasny Asset Management | 1.14 mm | $11.05 mm |
| JHG Janus Henderson | 1.11 mm | $10.76 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Jan 23 | Bryan Truman Hunt | Common Stock | Sell | Dispose S | No | Yes | 12.5332 | 2,354 | 29.50 k | 136,937 |
| 17 Jan 23 | Linda Llewelyn | Common Stock | Sell | Dispose S | No | Yes | 12.12 | 642 | 7.78 k | 49,707 |
| 17 Jan 23 | Bryan Truman Hunt | Common Stock | Sell | Dispose S | No | Yes | 12 | 2,055 | 24.66 k | 139,291 |
| 15 Dec 22 | Linda Llewelyn | Common Stock | Sell | Dispose S | No | Yes | 11.0031 | 642 | 7.06 k | 50,349 |
| 6 Dec 22 | Jason Alger | Common Stock | Sell | Dispose S | No | Yes | 10.3911 | 259 | 2.69 k | 33,762 |
| 1 Dec 22 | Burton Daniel D. | Common Stock | Payment of exercise | Dispose F | No | No | 10.6497 | 22,058 | 234.91 k | 878,082 |
News
Evercore ISI Group Downgrades Health Catalyst to In-Line, Raises Price Target to $11
3 Jan 23
12 Health Care Stocks Moving In Tuesday's After-Market Session
6 Dec 22
What 6 Analyst Ratings Have To Say About Health Catalyst
10 Nov 22
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
10 Nov 22
Analyst Ratings for Health Catalyst
10 Nov 22
Press releases
Health Catalyst Announces a New, External Leadership Assignment for Paul Horstmeier
6 Jan 23
Health Catalyst to Participate in Upcoming Investor Conference
20 Dec 22
Carle Health Partners with Health Catalyst to Achieve Data-Informed Improvement
5 Dec 22
Health Catalyst Reports Third Quarter 2022 Results
8 Nov 22